HB562

Prohibits Hawaii 340B entities from contracts restricting use of contract pharmacies and voids certain payment model provisions.

This bill aims to protect the integrity of the federal 340B drug pricing program in Hawaii by prohibiting 340B covered entities from entering into contracts with drug manufacturers that restrict the use of contract pharmacies. It also voids contract provisions based on the maximum allowable cost payment model. The bill authorizes the attorney general to bring civil actions for violations.